Xiaowei Chen – Trademark Portfolio
Entity Type: 01
Xiaowei Chen owns a portfolio of 11 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), including well-known marks such as DOSET, MAXREAL, WELIDAY, DEYEKUAC, and M-ACOUSTICS. Of these, 5 are registered and 1 is pending. The portfolio spans 6 Nice Classification classes, led by Class 9 (Computers & Electronics) and Class 21 (Housewares). Headquartered in Dongguan,Guangdong.
Hengli Village
Wangniudun Town
Dongguan,Guangdong 523219 , CN
Showing of trademarks Trademarks
Trademark Classifications
Xiaowei Chen's trademark portfolio spans 6 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Apparatus for lighting, heating, steam generating, cooking, refrigerating, drying
Leather and imitations of leather; animal skins, hides; trunks and travelling bags
Frequently Asked Questions
How many trademarks does Xiaowei Chen have?
Xiaowei Chen has 11 U.S. trademarks filed with the USPTO. Of these, 5 registered, 1 pending, 4 abandoned, 1 cancelled.
What trademark classes does Xiaowei Chen file in?
Xiaowei Chen files trademarks across 6 Nice Classification classes. The most active classes are Class 9 (Computers & Electronics), Class 21 (Housewares), Class 25 (Clothing), Class 11 (Environmental Control), Class 13 (Firearms). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.
What are Xiaowei Chen's most well-known trademarks?
Xiaowei Chen's registered trademark portfolio includes well-known marks such as DOSET, MAXREAL, WELIDAY, DEYEKUAC, and M-ACOUSTICS. These are among 5 currently registered trademarks in the portfolio.
What is Xiaowei Chen's trademark registration success rate?
Xiaowei Chen has a 50% trademark registration rate, with 5 out of 10 resolved applications resulting in successful registration. Currently, 1 application is pending review.